Clinical Trial Update: Evaluation of the Retina in Patients With Non-proliferative Diabetic Retinopathy After Aflibercept Injection in the Eye [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating aflibercept injections for non-proliferative diabetic retinopathy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy

Drugs mentioned

• Aflibercept (Aflibercept)

Snippet

Sponsor: University of Rochester | Conditions: Retinopathy, Diabetic | Phase 4 | Status: WITHDRAWN